Medical Supply Procurement – Lidocaine Hydrochloride Oral Topical Solution

The contract entails the supply of 2,000 bottles of Lidocaine Hydrochloride Oral Topical Solution, covering the full scope from formulation through packaging, labeling, and final shipment to a U.S. Navy vessel stationed overseas. The product must meet all regulatory and military specifications for pharmaceuticals, ensuring safety, efficacy, and compliance with U.S. Department of Defense standards. The delivery location is unspecified but confirmed to be external to the continental United States, requiring coordination with international logistics and customs protocols to guarantee timely receipt by the designated military unit. This is a subcontract under the Defense Logistics Agency, part of the Department of Defense, and falls under NAICS code 325412 for pharmaceutical and botanical product manufacturing. The contract was posted on July 15, 2026, indicating preparation for future procurement activity, with the ultimate fulfillment directed toward supporting medical readiness aboard naval vessels. All aspects of production and distribution must adhere to strict quality control measures, and the solution must be labeled and packaged in accordance with U.S. military and federal pharmaceutical guidelines to ensure operational use in remote or austere environments.